# Neuroregenerative Potential of Intravenous G-CSF and Autologous Peripheral Blood Stem Cells

> **NCT02983708** · PHASE1,PHASE2 · COMPLETED · sponsor: **Hanyang University Seoul Hospital** · enrollment: 57 (actual)

## Conditions studied

- Neurodegeneration
- G-CSF
- Peripheral Blood Mononuclear Cells
- Cerebral Palsy

## Interventions

- **BIOLOGICAL:** Peripheral blood mononuclear cells (mPBMC)
- **DRUG:** G-CSF
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02983708
- **Lead sponsor:** Hanyang University Seoul Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2016-12-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02983708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02983708, "Neuroregenerative Potential of Intravenous G-CSF and Autologous Peripheral Blood Stem Cells". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02983708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*